Modera:
Dra. María Luisa Fidalgo Andrés (Complejo Asistencial Universitario de León), Dr. Ángel Moya i Mitjans (Hospital Universitario Vall d’Hebron, Barcelona)
· Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2
Dra. María Luisa Fidalgo Andrés (Complejo Asistencial Universitario de León), Dr. Ángel Moya i Mitjans (Hospital Universitario Vall d’Hebron, Barcelona)
· Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2
Dr. Juan Bernal Rodríguez, CNIC Madrid
· Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia Dra. Georgia Sarquella Brugada, Hospital Sant Joan de Deu, Barcelona
· Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation Dr. Antonio Berruezo Sánchez, Hospital Clinic i Provincial, Barcelona
· Endo-epicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease Dra. María Teresa Izquierdo de Francisco, Hospital Clínico Universitario de Valencia
· Differential Responses of the Septal Ventricle and the Atrial Signals During Ongoing Entrainment: A Method to Differentiate Orthodromic Reciprocating Tachycardia Using Septal Accessory Pathways From Atypical Atrioventricular Nodal Reentry Dr. David Calvo Cuervo, Hospital Universitario Central de Asturias (HUCA)
· Increased intraventricular pressures are as harmful as the electrophysiological substrate of heart failure in favoring sustained reentry in the swine heart Dr. Jorge García Quintanilla, Hospital Clínico San Carlos, Madrid